Interventional Cardiology Devices Market

Interventional Cardiology Devices Market by type (Stents, Structural Heart, Catheters, Plaque Modification (Atherectomy), Hemodynamic Flow Alteration (Embolic Protection, Total Occlusion), Guidewire, Introducer Sheath, IVUS)) - Global Forecast to 2025

Report Code: MD 3456 Jan, 2021, by marketsandmarkets.com

[196 Pages Report] The global interventional cardiology devices market size is projected to reach USD 21.2 billion by 2025 from USD 13.8 billion in 2020, at a CAGR of 8.9% during the forecast period. Growth in this market is majorly driven by the rapid growth in the geriatric population and the associated increase in the prevalence of coronary artery diseases, the approval of new and advanced products, and the rising incidence of diabetes. However, the availability of alternative treatments and product failures and recalls are the major factors that are expected to restrain the growth of this market during the forecast period.

Interventional Cardiology Devices Market

To know about the assumptions considered for the study, Request for Free Sample Report

Covid -19 Impact On The Interventional Cardiology Devices Market

Globally, the outbreak of COVID-19 has impacted every aspect of the medical device industry, including the market for interventional cardiology devices. In the past six months, the number of patient visits to hospitals has reduced significantly, despite the fact that emergency and OPD services are available in cardiology departments. Nationwide lockdowns and social distancing measures have reduced patient visits significantly. This has further reduced the sales of interventional cardiology products. Many of the leading players in the interventional cardiology devices market, such as Boston Scientific, Medtronic, and Abbott, have registered a decline in sales for Q2 and Q3 of 2020

Global Interventional cardiology Devices Market Dynamics

Driver: growing prevalence of coronary artery diseases

According to the Centers for Disease Control and Prevention (CDC), coronary artery disease (CAD) is the most common type of heart disease in the US, killing 365,914 people in 2017. The CDC also estimates that nearly 18.2 million people above the age of 20 are currently suffering from CAD in the US. According to the British Heart Foundation, as of June 2020, there were 2.3 million people in the UK living with CAD. Each year, 170,000 people die from heart and circulatory diseases in the UK. Such a massive patient population and the high mortality rate is expected to increase the demand for interventional cardiology devices in the coming years.

Risk factors, such as diabetes and hypertension, also fuel the demand for interventional cardiology devices. People with diabetes are more likely to have other conditions that raise the risk of coronary heart disease. Over time, high blood sugar can damage the blood vessels that control the heart. According to the International Diabetes Federation (IDF), globally, the number of people suffering from diabetes is expected to reach 700 million by 2045 from 463 million in 2019. In the US alone, 1.5 million Americans are diagnosed with diabetes each year [Source: American Diabetes Association (ADA)]. Growth in diabetes prevalence can largely be attributed to the growth in the geriatric population; it is estimated that 25% of all geriatric individuals (aged 60 years and above) suffer from diabetes in the US (Source: ADA)

Global Incidence Of Diabetes, By Region, 2019 Vs. 2030 Vs. 2045

Interventional Cardiology Devices Market   by Region

According to an article published in the Lancet Journal in October 2016, the global prevalence of interventional cardiology diseases was 115.1 million in 2005, which rose to 154.6 million in 2015. With the growing geriatric population in all major regions across the globe, the prevalence of interventional cardiology diseases is expected to increase further in the coming years. This, in turn, will increase the demand and uptake of interventional cardiology devices in major markets during the forecast period.

Opportunity: Emerging Markets

India, China, and Brazil are relatively untapped markets for interventional cardiology. The high incidence of diabetes and the large geriatric population in these and other emerging countries offer significant growth opportunities for the interventional cardiology devices market.

According to the IDF, ~77.0 million people suffered from diabetes in India alone in 2019; this is projected to reach 101.0 million by 2030. Similarly, in China, the population suffering from diabetes is projected to reach 140.5 million by 2030, from 116.4 million in 2019.

Furthermore, in India, the disposable income reached 2,937.0 billion in 2019 from 2,818.0 billion in 2018 (Source: TRADING ECONOMICS). In addition, increasing health awareness in the aforementioned countries is expected to increase the demand for advanced treatment methods, including interventional cardiology.

Angiography catheters segment accounted for the largest share of the catheters market in 2019

Based on type, the catheters market is categorized into angiography catheters, guiding catheters, and IVUS/OCT catheters. Among all the angiography catheters segment accounted for the largest share of the catheters market in 2019. This is due to the high and increasing prevalence of coronary artery diseases (CAD), coupled with the growing awareness about the benefits of the early diagnosis of CADs.

Embolic protection devices accounted for the largest share of the interventional cardiology devices market in 2019

Based on type, the hemodynamic flow alteration devices market has been categorized into embolic protection devices and chronic total occlusion devices. Among both, the embolic protection devices segment accounted for the larger share of the hemodynamic flow alteration devices market in 2019. This can be attributed to the advantages of embolic protection devices over chronic total occlusion devices, such as the ability to capture embolic debris without interrupting continuous blood flow. Moreover, an increasing number of interventional procedures for treating coronary artery diseases.

Interventional Cardiology Devices Market   by Region

North America accounted for the largest share of the interventional cardiology devices market in 2019

Based on the region, the interventional cardiology devices market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2019, North America accounted for the largest share of the interventional cardiology devices market. The large share of North America can be attributed to factors such as the increasing prevalence of diabetes, rising aging population, availability of reimbursement, and the presence of all key players.

Prominent players in the interventional cardiology devices market are Medtronic (US), Boston Scientific Corporation (US), Abbott (US), Edward Lifescinces Corporation (US), Cardinal Health (US), iVascular (Spain), Becton, Dickinson, and Company (US), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Biosensors International Group (Singapore), and BIOTRONIK SE & Co. KG (Germany).

Scope of the report

Report Metric

Details

Market Size Available for Years

2018–2025

Base Year Considered

2019

Forecast Period

2020–2025

Forecast Units

Value (USD Billion)

Segments Covered

Product and region

Geographies Covered

North America (US and Canada), Europe (Germany, France, UK, Italy, Spain, and the RoE), APAC (Japan, China, India, Australia, and the RoAPAC), and the RoW (Latin America and the Middle East and Africa)

Companies Covered

Major 10 players covered, including:
Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), Edward Lifescinces Corporation (US) Cardinal Health (US), iVascular (Spain), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Biosensors International Group (Singapore), and BIOTRONIK SE & Co. KG (Germany)

This research report categorizes the interventional cardiology devices market into the following segments and subsegments:

By Product

  • Angioplasty Balloons
    • Old/Normal Balloons
    • Drug-eluting Balloons
    • Cutting and Scoring Balloons
  • Angioplasty Stents
    • Drug-eluting Stents
    • Bare-metal Stents
    • Bioabsorbable Stents
  • Structural Heart Devics
    • Aortic Valve Therapy Devices
    • Other Therapy Devices (Mitral valve, pulmonary valve and tricuspid valve and left atrial appendage therapy devices)
  • Catheters
    • Angiography Catheters
    • Guiding Catheters
    • IVUS/OCT Catheters
  • Plaque Modification Devices
    • Atherectomy Devices
    • Thrombectomy Devices
  • Hemodynamic Flow Alteration Devices
    • Embolic Protection Devices
    • Chronic Total Occlusion Devices
  • Other Devices
    • Guidewires
    • Vascular Closure Devices
    • Introducer Sheaths
    • Hemostasis Valves
    • Balloon Inflation Devices

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Rest of the World
    • Latin America
    • Middle East and Africa

Key Market Players

Key players in the interventional cardiology devices market are

Boston Scientific is the leading player in the interventional cardiology devices market. The company offers a wide range of guidewires, stents, catheters, angioplasty balloons, and structural heart devices. In the last three years, the company has been focusing on expanding its interventional cardiology portfolio by adopting various organic and inorganic strategies. Apart from this, the company has a strong presence in the US. As a result, in 2019, the company registered ~46% of its total interventional cardiology revenue from the US alone.

Recent Developments:

  • In 2020, Edward Lifesciences Corporation (US) has received Chinese regulatory approval for the SAPIEN 3 Transcatheter Heart Valve for the treatment of patients suffering from severe, symptomatic aortic stenosis (AS) who are unable to undergo open-heart surgery
  • In 2019, Medtronic (US) has received US FDA approval for its Next-Generation Evolut PRO+ TAVR System for the treatment of symptomatic severe aortic stenosis in patients
  • In 2019, Abbott (US) has received US FDA approval for its MitraClip Heart Valve Repair Device to treat mitral regurgitation

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 27)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           FIGURE 1 INTERVENTIONAL CARDIOLOGY DEVICES MARKET SEGMENTATION
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES
    1.8 LIMITATIONS OF THE CURRENT EDITION

2 RESEARCH METHODOLOGY (Page No. - 31)
    2.1 RESEARCH DATA
           FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Secondary sources
           2.1.2 PRIMARY DATA
           FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION
           2.2.1 BOTTOM-UP APPROACH
                    2.2.1.1 Bottom-up approach for the interventional cardiology devices market
           FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
           2.2.2 TOP-DOWN APPROACH
           FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
           2.2.3 GROWTH FORECAST
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
           FIGURE 6 DATA TRIANGULATION METHODOLOGY
    2.4 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. - 37)
           FIGURE 7 ANGIOPLASTY STENTS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
           FIGURE 8 STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
           FIGURE 9 CATHETERS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
           FIGURE 10 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
           FIGURE 11 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
           FIGURE 12 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
           FIGURE 13 OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
           FIGURE 14 GEOGRAPHIC SNAPSHOT OF THE INTERVENTIONAL CARDIOLOGY DEVICES MARKET

4 PREMIUM INSIGHTS (Page No. - 42)
    4.1 INTERVENTIONAL CARDIOLOGY DEVICES MARKET OVERVIEW
           FIGURE 15 INCREASING PREVALENCE OF CORONARY ARTERY DISEASES TO DRIVE GROWTH IN THE INTERVENTIONAL CARDIOLOGY DEVICES MARKET
    4.2 ANGIOPLASTY STENTS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
           FIGURE 16 DRUG-ELUTING STENTS TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2019
    4.3 NORTH AMERICAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY CATHETER TYPE AND COUNTRY
           FIGURE 17 THE US IS EXPECTED TO DOMINATE THE INTERVENTIONAL CARDIOLOGY DEVICES MARKET IN 2020
    4.4 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: GEOGRAPHIC SNAPSHOT
           FIGURE 18 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 46)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 19 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Growing prevalence of coronary artery disease
           FIGURE 20 GLOBAL INCIDENCE OF DIABETES, BY REGION, 2019 VS. 2030 VS. 2045
                    5.2.1.2 Rising tobacco consumption and increasing incidence of obesity
                    5.2.1.3 Favorable reimbursements for interventional cardiology procedures
           TABLE 1 REIMBURSEMENTS FOR INTERVENTIONAL CARDIOLOGY PROCEDURES IN THE US
           5.2.2 RESTRAINTS
                    5.2.2.1 Availability of alternative treatments
                    5.2.2.2 Low affordability and inaccessibility of cardiac surgeries in developing countries
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growth potential of emerging economies
                    5.2.3.2 Increasing number of product approvals
           TABLE 2 RECENT APPROVALS OF VARIOUS TYPES OF INTERVENTIONAL CARDIOLOGY DEVICES, 2018–2020
           5.2.4 CHALLENGES
                    5.2.4.1 Stringent regulatory requirements delaying the approval of cardiac devices
                    5.2.4.2 Product failures and recalls
    5.3 COVID-19 IMPACT ON THE INTERVENTIONAL CARDIOLOGY DEVICES MARKET
    5.4 PRICING ANALYSIS
           TABLE 3 INTERVENTIONAL CARDIOLOGY DEVICES, AVERAGE SELLING PRICES (USD)
    5.5 VALUE CHAIN ANALYSIS
           FIGURE 21 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES
    5.6 SUPPLY CHAIN ANALYSIS
           FIGURE 22 DIRECT DISTRIBUTION—THE PREFERRED STRATEGY FOR PROMINENT COMPANIES
    5.7 ECOSYSTEM ANALYSIS
    5.8 TECHNOLOGY ANALYSIS
    5.9 REGULATORY LANDSCAPE
    5.1 PESTLE ANALYSIS

6 ANGIOPLASTY STENTS MARKET, BY TYPE (Page No. - 58)
    6.1 INTRODUCTION
           TABLE 4 ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           6.1.1 DRUG-ELUTING STENTS
                    6.1.1.1 Drug-eluting stents hold the largest share of the angioplasty stents market
           TABLE 5 DRUG-ELUTING STENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 6 DRUG-ELUTING STENTS MARKET, BY REGION, 2018–2025 (THOUSAND UNITS)
           6.1.2 BARE-METAL STENTS
                    6.1.2.1 Increasing use of drug-eluting stents has limited the growth of the bare-metal stents market
           TABLE 7 BARE-METAL STENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 8 BARE-METAL STENTS MARKET, BY REGION, 2018–2025 (THOUSAND UNITS)
           6.1.3 BIOABSORBABLE STENTS
                    6.1.3.1 Bioabsorbable stents ensure the complete healing of the arteries—a key factor driving market growth
           TABLE 9 BIOABSORBABLE STENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 10 BIOABSORBABLE STENTS MARKET, BY REGION, 2018–2025 (THOUSAND UNITS)

7 STRUCTURAL HEART DEVICES MARKET, BY TYPE (Page No. - 63)
    7.1 INTRODUCTION
           TABLE 11 STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           7.1.1 AORTIC VALVE THERAPY DEVICES
                    7.1.1.1 Increasing prevalence of aortic valve stenosis to support the market growth
           TABLE 12 AORTIC VALVE THERAPY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 13 AORTIC VALVE THERAPY DEVICES MARKET, BY REGION, 2018–2025 (THOUSAND UNITS)
           7.1.2 OTHER THERAPY DEVICES
           TABLE 14 OTHER THERAPY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)

8 CATHETERS MARKET, BY TYPE (Page No. - 66)
    8.1 INTRODUCTION
           TABLE 15 CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           8.1.1 ANGIOGRAPHY CATHETERS
                    8.1.1.1 Angiography catheters hold the largest share of the catheters market during the forecast period
           TABLE 16 ANGIOGRAPHY CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
           8.1.2 GUIDING CATHETERS
                    8.1.2.1 Guiding catheters to account for the second-largest share of the catheters market during the forecast period
           TABLE 17 GUIDING CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
           8.1.3 IVUS/OCT CATHETERS
                    8.1.3.1 IVUS/OCT catheters to register the highest growth rate during the forecast period
           TABLE 18 IVUS/OCT CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)

9 ANGIOPLASTY BALLOONS MARKET, BY TYPE (Page No. - 70)
    9.1 INTRODUCTION
           TABLE 19 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           9.1.1 OLD/NORMAL BALLOONS
                    9.1.1.1 Low treatment costs associated with this technique to drive the growth of the old/normal balloons market
           TABLE 20 OLD/NORMAL BALLOONS MARKET, BY REGION, 2018–2025 (USD MILLION)
           9.1.2 DRUG-ELUTING BALLOONS
                    9.1.2.1 Rising number of regulatory approvals for drug-eluting balloons to drive market growth during the forecast period
           TABLE 21 DRUG-ELUTING BALLOONS MARKET, BY REGION, 2018–2025 (USD MILLION)
           9.1.3 CUTTING/SCORING BALLOONS
                    9.1.3.1 Use of cutting balloon-aided procedures is very limited since medication is the primary treatment for atherosclerosis
           TABLE 22 CUTTING/SCORING BALLOONS MARKET, BY REGION, 2018–2025 (USD MILLION)

10 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE (Page No. - 74)
     10.1 INTRODUCTION
           TABLE 23 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
             10.1.1 THROMBECTOMY DEVICES
                        10.1.1.1 Thrombectomy devices segment dominates the plaque modification devices market
           TABLE 24 THROMBECTOMY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
             10.1.2 ATHERECTOMY DEVICES
                        10.1.2.1 Growing use of lipid-modifying drugs for the treatment of atherosclerosis instead of atherectomy devices to limit market growth
           TABLE 25 ATHERECTOMY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)

11 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE (Page No. - 77)
     11.1 INTRODUCTION
           TABLE 26 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
             11.1.1 EMBOLIC PROTECTION DEVICES
                        11.1.1.1 Embolic protection devices to dominate the hemodynamic flow alteration devices market during the forecast period
           TABLE 27 EMBOLIC PROTECTION DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
             11.1.2 CHRONIC TOTAL OCCLUSION DEVICES
                        11.1.2.1 CTO devices market has witnessed tremendous innovations, thereby expanding the options available for physicians
           TABLE 28 CHRONIC TOTAL OCCLUSION DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)

12 OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE (Page No. - 80)
     12.1 INTRODUCTION
           TABLE 29 OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
             12.1.1 GUIDEWIRES
           TABLE 30 GUIDEWIRES MARKET, BY REGION, 2018–2025 (USD MILLION)
             12.1.2 VASCULAR CLOSURE DEVICES
           TABLE 31 VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
             12.1.3 INTRODUCER SHEATHS
           TABLE 32 INTRODUCER SHEATHS MARKET, BY REGION, 2018–2025 (USD MILLION)
             12.1.4 BALLOON INFLATION DEVICES
           TABLE 33 BALLOON INFLATION DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
             12.1.5 HEMOSTASIS HEART VALVES
           TABLE 34 HEMOSTASIS HEART VALVES MARKET, BY REGION, 2018–2025 (USD MILLION)

13 INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY REGION (Page No. - 84)
     13.1 INTRODUCTION
           TABLE 35 INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
     13.2 NORTH AMERICA
           FIGURE 23 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET SNAPSHOT
           TABLE 36 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 37 NORTH AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 38 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 39 NORTH AMERICA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 40 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 41 NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 42 NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 43 NORTH AMERICA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
             13.2.1 US
                        13.2.1.1 Availability of reimbursements for interventional cardiology procedures to support the market growth
           TABLE 44 REIMBURSEMENTS FOR INTERVENTIONAL CARDIOLOGY PROCEDURES, 2020
           TABLE 45 US: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 46 US: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 47 US: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 48 US: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 49 US: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 50 US: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 51 US: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
             13.2.2 CANADA
                        13.2.2.1 Rising incidence of target diseases to support the market growth
           TABLE 52 CANADA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 53 CANADA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 54 CANADA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 55 CANADA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 56 CANADA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 57 CANADA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 58 CANADA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
     13.3 EUROPE
           TABLE 59 EUROPE: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 60 EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 61 EUROPE: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 62 EUROPE: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 63 EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 64 EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 65 EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 66 EUROPE: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
             13.3.1 GERMANY
                        13.3.1.1 Germany holds the largest share of the European interventional cardiology devices market
           TABLE 67 GERMANY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 68 GERMANY: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 69 GERMANY: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 70 GERMANY: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 71 GERMANY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 72 GERMANY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 73 GERMANY: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
             13.3.2 FRANCE
                        13.3.2.1 Favorable government initiatives in France to support the growth of the interventional cardiology devices market in the country
           TABLE 74 FRANCE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 75 FRANCE: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 76 FRANCE: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 77 FRANCE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 78 FRANCE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 79 FRANCE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 80 FRANCE: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
             13.3.3 UK
                        13.3.3.1 High burden of target diseases to drive the market in the country
           TABLE 81 UK: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 82 UK: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 83 UK: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 84 UK: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 85 UK: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 86 UK: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 87 UK: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
             13.3.4 SPAIN
                        13.3.4.1 Growing geriatric population to increase the demand for interventional cardiology devices in the country
           TABLE 88 SPAIN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 89 SPAIN: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 90 SPAIN: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 91 SPAIN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 92 SPAIN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 93 SPAIN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 94 SPAIN: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
             13.3.5 ITALY
                        13.3.5.1 Rising levels of obesity to increase the demand for interventional cardiology devices in the country
           TABLE 95 ITALY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 96 ITALY: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 97 ITALY: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 98 ITALY: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 99 ITALY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 100 ITALY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 101 ITALY: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
             13.3.6 REST OF EUROPE
           TABLE 102 ROE: HEALTH EXPENDITURE (% OF GDP), 2010 VS. 2017
           TABLE 103 ROE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 104 ROE: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 105 ROE: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 106 ROE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 107 ROE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 108 ROE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 109 ROE: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
     13.4 ASIA PACIFIC
           FIGURE 24 ASIA PACIFIC: INTERVENTIONAL CARDIOLOGY DEVICES MARKET SNAPSHOT
           TABLE 110 ASIA PACIFIC: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 111 ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 112 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 113 ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 114 ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 115 ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 116 ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 117 ASIA PACIFIC: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
              13.4.1 JAPAN 
                        13.4.1.1 Japan dominates the Asia Pacific interventional cardiology devices market
           TABLE 118 JAPAN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 119 JAPAN: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 120 JAPAN: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 121 JAPAN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 122 JAPAN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 123 JAPAN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 124 JAPAN: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
             13.4.2 CHINA
                        13.4.2.1 Highest tobacco consumption in the world—a major factor driving market growth in China
           TABLE 125 CHINA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 126 CHINA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 127 CHINA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 128 CHINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 129 CHINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 130 CHINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 131 CHINA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
             13.4.3 INDIA
                        13.4.3.1 Increasing target patient population to drive the market in the country
           TABLE 132 INDIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 133 INDIA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 134 INDIA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 135 INDIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 136 INDIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 137 INDIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 138 INDIA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
             13.4.4 AUSTRALIA
                        13.4.4.1 Increasing prevalence of heart diseases to support the market growth
           TABLE 139 AUSTRALIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 140 AUSTRALIA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 141 AUSTRALIA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 142 AUSTRALIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 143 AUSTRALIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 144 AUSTRALIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 145 AUSTRALIA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
             13.4.5 REST OF ASIA PACIFIC
           TABLE 146 ROAPAC: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 147 ROAPAC: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 148 ROAPAC: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 149 ROAPAC: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 150 ROAPAC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 151 ROAPAC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 152 ROAPAC: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
     13.5 REST OF THE WORLD
           TABLE 153 ROW: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 154 ROW: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 155 ROW: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 156 ROW: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 157 ROW: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 158 ROW: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 159 ROW: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 160 ROW: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
             13.5.1 LATIN AMERICA
                        13.5.1.1 Latin America dominates the RoW interventional cardiology devices market
           TABLE 161 LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 162 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 163 LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 164 LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 165 LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 166 LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 167 LATIN AMERICA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
             13.5.2 MIDDLE EAST & AFRICA
                        13.5.2.1 Increasing prevalence of diabetes to support market growth in the Middle East & Africa
           TABLE 168 MIDDLE EAST & AFRICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 169 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 170 MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 171 MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 172 MIDDLE EAST & AFRICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 173 MIDDLE EAST & AFRICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 174 MIDDLE EAST & AFRICA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)

14 COMPETITIVE LANDSCAPE (Page No. - 138)
     14.1 OVERVIEW
           FIGURE 25 KEY DEVELOPMENTS IN THE INTERVENTIONAL CARDIOLOGY DEVICES MARKET, JANUARY 2017–NOVEMBER 2020
           FIGURE 26 MARKET EVOLUTION FRAMEWORK: JANUARY 2017 TO NOVEMBER 2020
     14.2 COMPETITIVE SCENARIO
             14.2.1 AGREEMENTS & PARTNERSHIPS
           TABLE 175 KEY AGREEMENTS & PARTNERSHIPS
             14.2.2 PRODUCT LAUNCHES & APPROVALS
           TABLE 176 KEY PRODUCT LAUNCHES & APPROVALS
             14.2.3 EXPANSIONS
           TABLE 177 KEY EXPANSIONS
             14.2.4 ACQUISITIONS
           TABLE 178 KEY ACQUISITIONS
             14.2.5 OTHER DEVELOPMENTS
           TABLE 179 OTHER DEVELOPMENTS
     14.3 MARKET SHARE ANALYSIS, 2019
           FIGURE 27 INTERVENTIONAL CARDIOLOGY DEVICES MARKET SHARE ANALYSIS, 2019
     14.4 COMPANY EVALUATION MATRIX
             14.4.1 STARS
             14.4.2 EMERGING LEADERS
             14.4.3 PERVASIVE PLAYERS
             14.4.4 PARTICIPANTS
           FIGURE 28 VENDOR DIVE: INTERVENTIONAL CARDIOLOGY DEVICES MARKET
     14.5 COMPETITIVE LEADERSHIP MAPPING (START-UPS/SMES)
             14.5.1 PROGRESSIVE COMPANIES
             14.5.2 STARTING BLOCKS
             14.5.3 RESPONSIVE COMPANIES
             14.5.4 DYNAMIC COMPANIES
           FIGURE 29 VENDOR DIVE MATRIX FOR START-UPS: INTERVENTIONAL CARDIOLOGY DEVICES MARKET

15 COMPANY PROFILES (Page No. - 147)
(Business overview, Products offered, Recent developments, MNM view)* 
     15.1 BOSTON SCIENTIFIC CORPORATION
           FIGURE 30 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2019)
     15.2 MEDTRONIC PLC
           FIGURE 31 MEDTRONIC PLC: COMPANY SNAPSHOT (2019)
     15.3 ABBOTT LABORATORIES
           FIGURE 32 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
     15.4 EDWARDS LIFESCIENCES CORPORATION
           FIGURE 33 EDWARD LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2019)
     15.5 TERUMO CORPORATION
           FIGURE 34 TERUMO CORPORATION: COMPANY SNAPSHOT (2019)
     15.6 CORDIS (A SUBSIDIARY OF CARDINAL HEALTH, INC.)
           FIGURE 35 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2019)
     15.7 B. BRAUN MELSUNGEN AG
           FIGURE 36 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2019)
     15.8 KONINKLIJKE PHILIPS N.V.
           FIGURE 37 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2019)
     15.9 IVASCULAR S.L.U.
     15.10 BIOSENSORS INTERNATIONAL
     15.11 BIOTRONIK SE & CO. KG
     15.12 PENUMBRA, INC.
           FIGURE 38 PENUMBRA, INC: COMPANY SNAPSHOT (2019)
     15.13 AMG INTERNATIONAL (A SUBSIDIARY OF Q3 MEDICAL)
     15.14 ENDOCOR GMBH
     15.15 INSITU TECHNOLOGIES, INC.
     15.16 MERIL LIFE SCIENCES PVT. LTD.
     15.17 ALVIMEDICA
     15.18 CARDIONOVUM GMBH
     15.19 SMT
     15.20 MEDINOL LTD.
     15.21 WELLINQ
     15.22 SCITECH
     15.23 COMED B.V. (A SUBSIDIARY OF LEPU MEDICAL TECHNOLOGY HOLDING)
     15.24 BALTON SP. Z O.O
     15.25 RONTIS
     15.26 STENTYS SA
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies. 

16 APPENDIX (Page No. - 189)
     16.1 INSIGHTS FROM INDUSTRY EXPERTS
     16.2 DISCUSSION GUIDE
     16.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     16.4 AVAILABLE CUSTOMIZATIONS
     16.5 RELATED REPORTS
     16.6 AUTHOR DETAILS

 

The study involved four major activities in estimating the current size of the interventional cardiology devices market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

Several stakeholders, such as interventional cardiology device manufacturers, vendors, and distributors; researchers; and doctors from hospitals and ambulatory surgery centers, were consulted for this report. The demand side of this market is characterized by significant use of interventional cardiology devices due to the increasing prevalence of atherectomy, thrombectomy, and the growing aging population across the globe. The supply side is characterized by advancements in technology and a shift towards advanced devices. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Breakdown Of Primary Participants:

Interventional Cardiology Devices Market  Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the interventional cardiology devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size-using the market size estimation processes-the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the interventional cardiology devices industry.

Report Objectives

  • To define, describe, and forecast the interventional cardiology devices market by product and region
  • To forecast the revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)
  • To identify the micromarkets with respect to drivers, industry-specific challenges, opportunities, and challenges affecting the growth of the market
  • To analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To profile the key players and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies
  • To track and analyze competitive developments such as partnerships, agreements, collaborations, acquisitions, product launches, and research and development activities in the interventional cardiology devices market.
COVID-19

Get in-depth analysis of the COVID-19 impact on the Interventional Cardiology Devices Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Interventional Cardiology Devices Market

Request For Special Pricing
Report Code
MD 3456
Published ON
Jan, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Interventional Cardiology Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home